JohnQuimbyDO

PubMed

• Comparison of Single, Averaged, and Pooled Urine Protein:Creatinine Ratios in Proteinuric Dogs Undergoing Medical Treatment.
  Shropshire, S.,Quimby, J.,Cerda, R.> ;J. Vet. Intern. Med.. 2017 Nov 25
• Limited sampling pharmacokinetics of subcutaneous ondansetron in healthy geriatric cats, cats with chronic kidney disease, and cats with liver disease.
  Fitzpatrick RL, Wittenburg LA, Hansen RJ, Gustafson DL, Quimby JM> ;J. Vet. Pharmacol. Ther.. 2016-08-01
• Novel treatment strategies for feline chronic kidney disease: A critical look at the potential of mesenchymal stem cell therapy.
  Quimby JM, Dow SW> ;Vet. J.. 2015-06-01
• Oral, subcutaneous, and intravenous pharmacokinetics of ondansetron in healthy cats.
  Quimby JM, Lake RC, Hansen RJ, Lunghofer PJ, Gustafson DL> ;J. Vet. Pharmacol. Ther.. 2014-08-01
• Relationship among serum creatinine, serum gastrin, calcium-phosphorus product, and uremic gastropathy in cats with chronic kidney disease.
  McLeland SM, Lunn KF, Duncan CG, Refsal KR, Quimby JM> ;J. Vet. Intern. Med.. 2014-01-01
• Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
  Quimby, J. M.,Lunn, K. F.> ;Vet. J.. 2013 Jul 11
• Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats.
  Quimby, J. M.,Gustafson, D. L.,Samber, B. J.,Lunn, K. F.> ;J. Vet. Pharmacol. Ther.. 2010 Oct 26
• Adverse neurologic events associated with voriconazole use in 3 cats.
  Quimby, J. M.,Hoffman, S. B.,Duke, J.,Lappin, M. R.> ;J. Vet. Intern. Med.. 2010 Apr 14
• The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control cats.
  Quimby, J. M.,Gustafson, D. L.,Lunn, K. F.> ;J. Vet. Intern. Med.. 2011 Oct 12
• Join now to see all